MCDC Leadership
Peter Arvan, M.D., Ph.D.
Director, Michigan Comprehensive Diabetes Center
Division Chief, Metabolism, Endocrinology & Diabetes
Professor, Internal Medicine
Brehm Professor of Type 1 Diabetes Research
Dr. Peter Arvan received his undergraduate degree from Cornell University and a doctorate in cell biology from the Yale University School of Medicine, where he also pursued his residency and research fellowship in endocrinology. He spent eight years on the faculty at Harvard University working at what is now called the Beth Israel-Deaconess Medical Center, and seven years on the faculty of Albert Einstein College of Medicine in New York. In 2003, he joined the University of Michigan as chief of the Division of Metabolism, Endocrinology & Diabetes to assume the Brehm Professorship and brought along a large portion of his research team.
Dr. Arvan’s research focuses on increasing medicine’s understanding of insulin synthesis and secretion, and how insulin synthesis is linked to pancreatic beta cell survival (or demise) in normal individuals and people with diabetes.
Dr. Arvan is a past recipient of a PEW Foundation scholarship in the biomedical
sciences, a Wellcome Visiting Professorship in the basic medical sciences and
winner of the R.R. Bensley award from the American Association of Anatomy.
He is the principal investigator on two NIH-funded RO1 grants and consults on a third. He also has been awarded funding from the American Diabetes Association.
He has served as a reviewer for 15 specialty journals and is currently
on the editorial board of the American Journal of Physiology: Endocrinology
and Metabolism. He also is a member of numerous scientific societies and
is frequently invited to speak at national and international conferences.
Since 2003, Arvan has established his clinical practice and has been recently
named one of Hour Detroit Magazine’s “2006 Top Docs.”
Martin G. Myers, Jr., M.D., M.P.H.
Director, Michigan Diabetes Research & Training Center
Associate Professor, Internal Medicine and Molecular & Integrative Physiology Marilyn H. Vincent Professor of Diabetes Research
Dr. Myers received his bachelor’s degree from Princeton University, and his MD and PhD from Harvard University. His first independent research program was at the Joslin Diabetes Center/Harvard Medical School; he joined the University of Michigan faculty in 1994.
Dr. Myers’ research focuses on the action of the hormone, leptin. Leptin is an adipose-derived hormone that signals the status of long-term energy stores to the brain, decreasing feeding and permitting energy utilization via a variety of neuroendocrine functions. The Myers lab studies leptin action along two broad themes: Mechanisms of intracellular signaling, and the neural basis of leptin action. Revealing these mechanisms may reveal potential targets for therapeutic intervention in obesity and diabetes. Research in the Myers lab is funded by the National Institutes of Health, the American Diabetes Association, and the American Heart Association.
Dr. Myers has received numerous awards for his research achievements, including the Jerome Conn Award and the Basic Science Research Award from the University of Michigan, as well as Outstanding Scientific Achievement Awards from The Obesity Society and from the American Diabetes Association, and the Ernst Oppenheimer Award from the Endocrine Society.
Frank C. Brosius III, M.D.
Director, Diabetic Complications Consortium
Division Chief, Nephrology
Professor, Internal Medicine and Molecular & Integrative
Physiology
Dr. Frank C. Brosius III received his medical degree from the University of Kansas and completed his residency at the University of Michigan. Prior to joining the U-M faculty, Dr. Brosius completed fellowships ats the National Institutes of Health in Bethesda, Maryland, the Beth Israel Hospital in Boston, Massachusetts, and his post doctorate at the Whitehead Institute in Cambridge, Massachusetts.
Dr. Brosius is director of the University of Michigan/University of Chicago unit of the Diabetic Complications Consortium. The consortium, sponsored by the National Institutes of Health, is developing and testing new animal models of diabetic complications to help researchers better test new theories and treatments.
Dr. Brosius’ research interest focuses on curing and stabilizing
diabetic kidney disease, and understanding how glucose transport leads to altered
kidney and vascular function in diabetic kidney disease and hypertension.
Charles F. Burant, M.D., Ph.D.
Director, Michigan Metabolomics and Obesity Center / Michigan Nutrition Obesity Research Center
Professor, Internal Medicine
Professor, Molecular & Integrative Physiology
Adjunct Associate Professor, Kinesiology
Robert C. and Veronica Atkins Professor of Metabolism
As director of the Michigan Metabolomics and Obesity Center, Dr. Charles F. Burant facilitates the network of obesity-related researchers on the U-M campus, which results in enhancing collaborative studies and speeding the translation of basic science findings into clinically useful therapies for metabolic diseases including obesity, Type 2 diabetes and related metabolic disorders.
Dr. Burant earned both his medical degree and doctorate of philosophy
in molecular and cellular biology from the Medical University of
South Carolina in Charleston. His internship and residency were served
at the University of California, San Francisco, and he completed his
fellowship in the Department of Medicine, Endocrinology Section at the
University of Chicago. He joined the University of Michigan
faculty in 1999.
Eva L. Feldman, M.D., Ph.D.
Director, Center for the Study
of Diabetes Complications
Director, Amyotrophic Lateral Sclerosis
Clinic
Director, A. Alfred Taubman Medical Research Institute
Russell N. DeJong Professor
of Neurology
Dr. Eva Feldman is the director of the Center for the Study of Diabetes Complications (formerly the Juvenile Diabetes Research Foundation for the Study of Complications in Diabetes), the Russell N. DeJong Professor of Neurology, and is the director for the Amyotrophic Lateral Sclerosis (ALS) Clinic.
Dr. Feldman received her medical degree from the University of Michigan and completed a neurology residency at the Johns Hopkins Hospital, where she served as Chief Resident. She completed a fellowship in clinical neuromuscular disease at the University of Michigan and officially joined the University of Michigan Medical Center in 1988.
Dr. Feldman's current investigative activities emphasize an understanding of the pathogenesis and treatment of neuromuscular disorders with an emphasis on diabetic neuropathy and ALS.
William H. Herman, M.D., M.P.H.
Director, Michigan Center for Diabetes Translational Research
Chief, Prevention and Control Division, Michigan Diabetes Research and Training Center
Professor, Internal Medicine
Stefan S. Fajans/GlaxoSmithKline Professor of Diabetes
Dr. William H. Herman serves as Director for the Michigan Center for Diabetes Translational Research, established in 2011, as well as Chief of the Prevention and Control Division for the Michigan Diabetes Research and Training Center (MDRTC).
Dr. Herman received his medical degree from Boston University, a master of public health in epidemiology at University of Michigan, and joined the University of Michigan faculty in 1995.
Dr. Herman’s research focuses on diabetes, its treatments and complications. In addition he studies diabetes epidemiology, managed care and health economics.
